Three companies led by Indian origin entrepreneurs — Qure.ai led by Prashant Warier, CRISPR Therapeutics led by Sam Kulkarni ...

Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with hard-to-manage glycemia.

Meet 12 biotech companies with promising genetic disease therapies that successfully closed funding rounds recently.

Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...

A lawsuit filed in federal court on behalf of the University of Pennsylvania and its health system alleges that 20 years of skyrocketing prices on drugs that treat diabetes, like insulin, can be ...

Amy and Kameel each bring an extraordinary combination of strategic vision, operational excellence, and hands-on experience developing and commercializing therapies in complex neurological and chronic ...

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

The patent allows a broad cell-based immunotherapy approach to treating Type 1 diabetes using the ImmCelz TM product, which includes the supercharged T regulatory cells using the Company’s proprietary ...

Researchers conducted the QWINT-1 and QWINT-2 clinical trials to assess glycemic and patient-reported outcomes among those using once-weekly insulin efsitora.

The shares of the prominent pharmaceutical company gained up to 4 percent in today's trading session after the company ...

The UCSF community is saddened at the passing of former UCSF faculty member William Rutter, PhD, whose collaborative and ...

From Insulin Innovations to Scandal" Novo Nordisk is a pharmaceutical powerhouse, dominating Europe as its largest company and producing life-saving insulin that millions depend on. But behind this ...